Initial clinical trials for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines excluded pregnant women. Thus, pregnant women's immune response to vaccination and the transplacental transfer of maternal antibodies to the fetus is not yet studied in detail. Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth.